Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
28 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-pharmaceutical-taiho-oncology-and-cullinan-therapeutics-announce-primary-endpoint-met-in-phase-2b-trial-of-zipalertinib-in-patients-with-non-small-cell-lung-cancer-harboring-egfr-exon-20-insertion-mutations-who-have-receiv-302362492.html
24 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-presents-real-world-findings-for-lonsurf-at-the-asco-gastrointestinal-cancers-symposium-302360059.html
14 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-announces-decitabine-and-cedazuridine-to-be-included-in-nih-precision-medicine-trials-302350281.html
09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-data-at-ash-annual-meeting-highlight-progress-in-oral-therapies-for-patients-with-blood-cancers-302326319.html
05 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-to-present-data-at-the-66th-american-society-of-hematology-annual-meeting-302296677.html
23 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-announces-publication-of-final-results-of-the-phase-3-ascertain-clinical-trial-of-oral-decitabine-and-cedazuridine-fixed-dose-combination-inqovi-in-patients-with-mds-and-cmml-302041085.html
ABOUT THIS PAGE